Kura Oncology, Inc. (NASDAQ: KURA) shares rose on Wednesday February 8 on lower trade volume than normal after a number of analysts weighed in on the investing value of the stock, increasing the price target of stock.
Meanwhile U.S. stocks traded modestly lower on Wednesday, as losses in energy shares following a drop in oil prices and a slide in financials weighed on the main indexes.
The S&P 500 index SPX, -0.17% declined 6 points, or 0.3%, to 2,286, with six of the main sectors trading lower. Energy and financials were leading the losses, down more than 1%.
The Dow Jones Industrial Average DJIA, -0.26% was down 65 points, or 0.3%, to 20,021, a day after the blue-chip index set an intraday high at 10,155.35. The Nasdaq Composite COMP, -0.13% retreated from an all-time high set on Tuesday, falling 23 points, or 0.4%, to 5,650.
Kura Oncology, Inc. (NASDAQ: KURA) had its price target raised by equities researchers at Cann from $0.00 to $18.00. Cann currently has a rating of Outperform on the stock. A number of other analysts have issued reports on the company recently, and the company has earned a consensus one-year price target of $14.33, higher than the opening price of $6.35. Kura Oncology, Inc. stock has a 52-week high of $7.24.
Shares of Kura Oncology, Inc. (NASDAQ: KURA) opened at $6.35 yesterday and traded in a range between, $6.20 and $6.55, and last traded at $6.33, which represents an increase of $0.13 from the previous closing price.
Kura Oncology, Inc. (NASDAQ: KURA) currently has a market cap of 120.46M.
Kura Oncology, Inc. (NASDAQ: KURA) Average Daily Trading Volume
4,329 shares crossed the trading desk yesterday, 24 percent below the norm, out of a total float 10,698,000. lower than normal. Look for trading volume to pick up in the coming days as investors often use increases in trading volume to identify heavy volume accumulation or distribution by institutional investors.
As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.
Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.
Institutional investors such as these have teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.
Kura Oncology, Inc. (NASDAQ: KURA) Moving Averages
A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.
This is because the average acts like a floor (support), so the price bounces up off of it.
In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.
By identifying trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.
Trades for Kura Oncology, Inc. (NASDAQ: KURA) have ranged from $2.50 – 7.240, and the stock now has a 50-day MA of $6.18 and 200-day MA of $5.56. Today’s last price is 12.64%% lower than the 52 week high of $7.24.
Earnings growth is an important factor to look at when buying stocks and investors seek companies that have raised their earnings at least 25% or more over a 3 year period.
DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.